DAFTER PUSTAKA

1. Hermawan A.G. 2009. Sepsis daalam Sudoyo, Aru W. Setiyohadi, Bambang.

Alwi, Idrus. Simadibrata K, Marcellus. Setiati, Siti. Buku Ajar Ilmu Penyakit
Dalam Jilid III Edisi V. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit
Dalam FKUI.
2. Surviving Sepsis Campaign. International Guidelines for Management of Severe
Sepsis and Septic Shock: 2012. Critical Care Medicine Februari 2013; 41(2): 585-
636
3. Surviving Sepsis Campaign. International Guidelines for Management of Severe
Sepsis and Septic Shock: 2016. Critical Care Medicine Oktober2016;315(8):801-
810
4. Angus DC, Linde WT, Lidicker J. Epidemiology of Severe Sepsis In The United
States. Crit Care Med. 2001;20:1303-31.
5. Harrison DA, Welch CA, Eddleston JM: The epidemiology of severe sepsis in
England,Wales, and Northern Ireland, 1996 to 2004: secondary analysis of a high
quality clinicaldatabase, the ICNARC Case Mix Programme Database. Crit care
2006: 10(2); R42.
6. Rivers E, Nguyen B, et al: Early goal directed therapy in the treatment of severe
sepsis andseptic shock. N Engl J Med 2001; 345: 1368-77.
7. Reinhardt K, Bloos K, Brunkhorst FM. Pathophysiology of Sepsis and Multiple
Organ Dysfunction. In: Fink MP, Abraham E, Vincent JL, eds. Textbook of critical
care. 15th ed. London: Elsevier Saunders Co; 2005. p.1249-57.
8. Singer M, Deutschman CS, Seymour CW , Hari MS, Annane D, Bauer M, et al.
The Third International Consensus Definitions for Sepsis and Septic Shock
(Sepsis-3). JAMA.2016;315(8):801-810.
9. Chan YL Tseng CP, Tsay PK, et al: Procalcitonin as marker of bacterial infection
inemergency department: an observational study. Crit Care 2004; 8:r 12-R20.
10. Lobo SM, Lobo FR, Bota DP: C reactive protein levels correlate with mortality
and organfailure in critically ill patient. Chest. 2003; 123: 2043-9